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Abstract 
Curcumin is a perspective drug candidate with pleiotropic antineoplastic activity, whose 
exceptionally low aqueous solubility and poor pharmacokinetic properties have hampered its 
development beyond the preclinical level. A possible approach to overcome these limitations 
is the encapsulation of curcumin into nano-carriers, incl. liposomes. The present contribution 
is focused on feasibility of using hybrid pH-sensitive liposomes, whereby curcumin is 
entrapped as a free drug and as a water soluble inclusion complex with PEGylated tert-
butylcalix[4]arene, which allows the drug to occupy both the phospholipid membranes and the 
aqueous core of liposomes. The inclusion complexes were encapsulated in 
dipalmithoylphosphathydilcholine:cholesterol liposomes, whose membranes were grafted with 
a poly(isoprene-b-acrylic acid) diblock copolymer to confer pH-sensitivity. The liposomes were 
characterized by DLS, ζ-potential measurements, cryo-TEM, curcumin encapsulation efficacy, 
loading capacity, and in vitro release as a function of pH. Free and formulated curcumin were 
further investigated for cytotoxicity, apoptosis-induction and caspase-8, and 9 activation in 
chemosensitive HL-60 and its resistant sublines HL-60/Dox and HL-60/CDDP. Formulated 
curcumin was superior cytotoxic and apoptogenic agent vs. the free drug. The mechanistic 
assay demonstrated that the potent proapoptotic effects of pH-sensitive liposomal curcumin 
presumably mediated via recruitment of both extrinsic and intrinsic apoptotic pathways in both 
HL-60 and HL-60/CDDP cells. 
